Evidence map›Paper›PMID 36826881›Full record

ArticleJournal of functional biomaterials2023

Hyaluronic Acid Hydrogel Containing Resveratrol-Loaded Chitosan Nanoparticles as an Adjuvant in Atopic Dermatitis Treatment.

Raffaele Conte, Ilenia De Luca, Anna Valentino, Pierfrancesco Cerruti, Parisa Pedram, Gustavo Cabrera-Barjas, Arash Moeini, Anna Calarco

Open access · goldAbstract read
In one paragraph

Article in Journal of functional biomaterials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Raffaele ConteAMES Group Polydiagnostic Center, Via Padre Carmine Fico, 24, 80013 Casalnuovo di Naples, Italy.ORCID 0000-0002-6266-4991
Ilenia De LucaResearch Institute on Terrestrial Ecosystems (IRET)-CNR, Via Pietro Castellino 111, 80131 Naples, Italy.ORCID 0000-0003-3776-6627
Anna ValentinoResearch Institute on Terrestrial Ecosystems (IRET)-CNR, Via Pietro Castellino 111, 80131 Naples, Italy.ORCID 0000-0001-8041-2221
Pierfrancesco CerrutiInstitute of Polymers, Composites and Biomaterials (IPCB)-CNR, Via Campi Flegrei, 34, 80078 Pozzuoli, Italy.ORCID 0000-0003-0822-2866
Parisa PedramLehrstuhl für Brau- und Getränketechnologie, School of Life Sciences, Technische Universität München (TUM), 85354 Freising, Germany.
Gustavo Cabrera-BarjasUnidad de Desarrollo Tecnológico (UDT), Universidad de Concepción, Avda. Cordillera No. 2634, Parque Industrial Coronel, Coronel 4191996, Chile.ORCID 0000-0002-1850-0244
Arash MoeiniLehrstuhl für Brau- und Getränketechnologie, School of Life Sciences, Technische Universität München (TUM), 85354 Freising, Germany.ORCID 0000-0002-0157-1994
Anna CalarcoResearch Institute on Terrestrial Ecosystems (IRET)-CNR, Via Pietro Castellino 111, 80131 Naples, Italy.ORCID 0000-0002-1441-7662
Technical University of Munich · DEInstitute of Polymers, Composites and Biomaterials · ITUniversity of Concepción · CL

Funding

Allianz Industrie Forschung (AiF) ZF4025045AJ9AND FONDECYT REGULAR 1221609POR Campania FESR 2014_2020 "Tecnologie abilitanti per la sintesi eco-sostenibile di nuovi ma-teriali per la restaurativa dentale" - ABILTECH; EU funding within the Horizon 2020 Program, under the MSCA-RISE 2016 Project "VAHVISTUS" 734759: Sviluppo di nanotecnologie Orientate alla Rigenerazione e Ricostruzione tissutale, Implanto-lo-gia e Sensoristica in Odontoiatria/oculistica (SORRISO) PON 03 PE_00110_1/ptd1_000410
6 · The paper itself

Abstract

Atopic dermatitis (AD) is a common disease-causing skin inflammation, redness, and irritation, which can eventually result in infection that drastically impacts patient quality of life. Resveratrol (Res) is a natural phytochemical famed for its excellent anti-inflammatory and antioxidant activities. However, it is poorly bioavailable. Thus, a drug delivery system is needed to enhance in vivo bioactivity. Herein, we report the preparation of hyaluronic acid (HA) hydrogels containing resveratrol-loaded chitosan (CS) nanoparticles, their physicochemical analysis, and their potential therapeutic effects in the treatment of AD. Positively charged CS nanoparticles prepared by tripolyphosphate (TPP) gelation showed sizes ranging from 120 to around 500 nm and Res encapsulation efficiency as high as 80%. Embedding the nanoparticles in HA retarded their hydrolytic degradation and also slowed resveratrol release. Resveratrol released from nanoparticle-loaded hydrogel counteracted the oxidative damage induced by ROS generation in TNF-α/INF-γ-treated human keratinocytes (HaCaT) used as an AD in vitro model. Moreover, pre-treatment with Res@gel reduced secretion and gene expression of proinflammatory cytokines in HaCaT cells. The physicochemical analysis and in vitro assay confirmed that the formulated hydrogel could be considered an efficient and sustained resveratrol delivery vector in AD treatment.

Indexed as

anti-inflammatoryantioxidantatopic dermatitischitosanhyaluronic acidhydrogelnanoparticlesresveratrol

Identifiers

PMID36826881
PMCPMC9959248
OpenAlexW4318776579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.